Coverage
-
May 05, 2022
The former CEO of Auspex Pharmaceuticals Inc. will pay just over $56,000 to end both a U.S. Securities and Exchange Commission suit and a related criminal case against him over insider trading accusations that he tipped off his inner circle ahead of his company's $3.2 billion acquisition by Teva.
1 other articles on this case.
View all »